Saturday 17 October 2026
Export MENS’s income statement to Excel — free account
Jyong Biotech Ltd.
MENS Healthcare Biotechnology
1.84
0.14
−7.07%
Follow MENS
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
Current Ratio |
0.45 | 0.02 | 0.13 |
Net Debt/EBITDA |
(6.89) | (9.22) | (5.52) |
Debt/Assets |
88.76% | 282.12% | 199.95% |
Debt/Equity |
(0.74) | (0.49) | (0.48) |
Asset Turnover |
0.00 | 0.00 | — |
Operating CF/Net income |
0.65 | 1.20 | 0.59 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 |
Interest Coverage |
(1.03) | (1.99) | (3.69) |
| 15.21% | 8.55% | 0.00% | |
| (34.42%) | (41.32%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
28.87% | 34.03% | 48.71% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.04) | (0.05) | (0.04) |
Cash per Share |
0.02 | 0.00 | 0.02 |
Shareholders Equity per Share |
(0.34) | (0.51) | (0.48) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(0.34) | (0.51) | (0.48) |
Free Cash Flow |
(3.04) | (3.62) | (2.60) |
Working Capital |
(19.27) | (11.92) | (12.42) |
Net Current Asset Value |
(30.14) | (42.68) | (40.48) |
| Other line items | |||
Quick Ratio |
0.03 | 0.01 | 0.12 |
Depreciation/Fixed assets |
0.03 | 0.04 | 0.04 |
Cash ROIC |
57.53% | 19.63% | 16.42% |
Accounts Payable Turnover |
0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.04) | (0.05) | (0.04) |
Capex per Share |
0.00 | 0.00 | 0.00 |
Average Payables |
0.00 | 0.00 | — |
Average Assets |
13.57 | 7.31 | — |
Average Common Equity |
(30.71) | (35.30) | — |
Columns are period end dates